The reaction of 1-alkynes with acyl azides in the presence of [Tpm(*,Br)Cu(NCMe)]BF(4) [Tpm(*,Br) = tris(3,5-dimethyl-4-bromopyrazolyl)methane] as the catalyst provides 2,5-oxazoles in moderate to high yields. This is a novel transformation of the CuAAC type that constitutes a significant variation of the commonly observed [3 + 2] cycloaddition reaction to yield 1,2,3-triazoles.
No takes yet. Share an insight, caveat, or question.
Cano et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: